JP Morgan Chase
COLL icon

JP Morgan Chase’s Collegium Pharmaceutical COLL Stock Holding History

JP Morgan Chase’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-90,000
Closed -$1.33M – 5710
2018
Q3 		$1.33M Buy
+90,000
New +$1.6M ﹤0.01% 3730

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

JP Morgan Chase's COLL Position: Q1 2026 in Review

JP Morgan Chase increased its Collegium Pharmaceutical (COLL) stake by 2.5% in Q1 2026, buying an estimated $113K and bringing the position to 110,702 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3643.

JP Morgan Chase first reported a position in COLL in Q4 2015 and has held it in 39 quarters since. The position peaked at $10.7M in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • JP Morgan Chase held 110,702 shares of Collegium Pharmaceutical worth $3.54M as of Q1 2026.
  • JP Morgan Chase bought 2,663 Collegium Pharmaceutical shares in Q1 2026, an estimated $113K.
  • Collegium Pharmaceutical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3643 holding.
  • JP Morgan Chase first reported a position in Collegium Pharmaceutical in Q4 2015 and has held it in 39 quarters since.
  • JP Morgan Chase's Collegium Pharmaceutical position peaked at $10.7M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.